SRB Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-9,445
Closed -$2.17M 108
2021
Q2
$2.17M Buy
9,445
+2,178
+30% +$437K 0.14% 12
2021
Q1
$1.36M Buy
7,267
+1,926
+36% +$377K 0.09% 90
2020
Q4
$902K Buy
5,341
+1,505
+39% +$225K 0.07% 19
2020
Q3
$567K Buy
+3,836
New +$594K 0.05% 82
2014
Q4
Sell
-2,230
Closed -$145K 196
2014
Q3
$145K Buy
+2,230
New +$141K 0.02% 33

Other funds holding LLY

SRB Corp's LLY Position: Q3 2021 in Review

SRB Corp sold out of Eli Lilly (LLY) in Q3 2021, closing a stake of 9,445 shares — an estimated $2.17M sold.

SRB Corp first reported a position in LLY in Q3 2014 and held it in 5 quarters. The position peaked at $2.17M in Q2 2021. 2,051 funds tracked by Wall St. Rank hold LLY as of Q3 2021.

  • SRB Corp reported no remaining Eli Lilly position as of Q3 2021 after selling out during the quarter.
  • SRB Corp sold 9,445 Eli Lilly shares in Q3 2021, an estimated $2.17M.
  • SRB Corp first reported a position in Eli Lilly in Q3 2014 and held it in 5 quarters.
  • SRB Corp's Eli Lilly position peaked at $2.17M in Q2 2021.
  • 2,051 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2021.

Based on SRB Corp's 13F filing for Q3 2021, filed 12 Nov 2021.